Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia

Int J Antimicrob Agents. 2014 Apr;43(4):391-3. doi: 10.1016/j.ijantimicag.2014.01.020. Epub 2014 Feb 22.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia / drug therapy
  • Cefepime
  • Cephalosporins / therapeutic use
  • Ciprofloxacin / therapeutic use*
  • Colistin / therapeutic use*
  • Drug Resistance, Multiple, Bacterial / genetics
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunocompromised Host
  • Meropenem
  • Pseudomonas Infections / blood
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / genetics
  • Pseudomonas aeruginosa / pathogenicity
  • Thienamycins / therapeutic use
  • Tobramycin / therapeutic use
  • Treatment Failure

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Thienamycins
  • Ciprofloxacin
  • Cefepime
  • Meropenem
  • Tobramycin
  • Colistin